RecruitingPhase 3NCT04965675
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Sponsor: H. Lundbeck A/S
New Haven, CT · Stamford, CT · +20 more sites
Migraine clinical trials in Stamford, CT
10 recruiting migraine studies with a site in Stamford, CT.
RecruitingPhase 3NCT05164172
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
Sponsor: H. Lundbeck A/S
New Haven, CT · Stamford, CT · +18 more sites
RecruitingPhase 3NCT05897320
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Sponsor: H. Lundbeck A/S
Stamford, CT · +14 more sites
RecruitingPhase 3NCT07816367
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Sponsor: Kallyope Inc.
Stamford, CT · +71 more sites
RecruitingPhase 2NCT07646613
Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
Sponsor: Aspeya, Inc.
Stamford, CT · Waterbury, CT · +18 more sites
RecruitingPhase 2NCT07616128
Study of EVO756 in Adults With Migraine
Sponsor: Evommune, Inc.
New Haven, CT · Stamford, CT · +31 more sites
RecruitingPhase 3NCT04649242
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Sponsor: Pfizer
Cromwell, CT · Hartford, CT · Stamford, CT · +166 more sites
RecruitingPhase 3NCT04743141
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Sponsor: Pfizer
Cromwell, CT · Stamford, CT · +113 more sites
RecruitingPhase 3NCT05125302
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Sponsor: AbbVie
Stamford, CT · +124 more sites
RecruitingPhase 4NCT04748601
Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
Sponsor: Upsher-Smith Laboratories
Stamford, CT · +14 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.